Back

Bioprosthetic valves longevity in the pulmonary position in adults with congenital heart disease

2 September 2019 (15:45 - 16:35)
Organised by:
Congress Presentation Part of: Hot topics in treatment of congenital heart disease Adult Congenital Heart Disease (ACHD) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Alexander Egbe

Mayo Clinic, Rochester (United States of America)

6 More presentations in this session

Presentation thumbnail
Safety and efficacy of triple combination therapy with parenteral prostanoids in patients with Eisenmenger physiology
Doctor M. D'Alto (Naples, IT)
Abstract Slides
Presentation thumbnail
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
Doctor E. Freisinger (Munster, DE)
Abstract
Presentation thumbnail
Long term comparison between homograft vs stented bio-prostheses for pulmonary valve replacement in tetralogy of fallot patients
Doctor L. cocomello (Bristol, GB)
Abstract Slides
Presentation thumbnail
Transcatheter pulmonary valve implantation versus surgical pulmonary conduit replacement in corrected tetralogy of Fallot with pulmonary atresia: a propensity matched comparison
Doctor D. Dorobantu (Bristol, GB)
Abstract Slides
Presentation thumbnail
Influence of restrictive right ventricular physiology in outcomes after transcatheter pulmonary valve implantation in adult patients
Doctor A. Francisco (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Hot topics in treatment of congenital heart disease

The Event

Event poster

ESC Congress 2019

2 September 2019 15:45 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources